LUCIUS 卢修斯 泊马度胺 Pomalidomide多发性骨髓瘤 卡波济氏肉瘤

泊马度胺

药监局注册文号:12L 1283/24
美国FDA批准上市产品,疗效确切

Pomalidomide

卢修斯制药(老挝)有限公司出品
老挝国家食药监局批准上市
老挝国家药检所检测认证
多发性骨髓瘤

Compesition:
Each capsale contains Pomalidomide .......

卡波济氏肉瘤

LuciPona is a thalido

LUCIUS

Lucirea is a tnalidomde ansloone

PHARMACEUTICALS

combination with dexamethasone, for parients
least two pror therapies inc luding lenalidomide anda
proteasome inhibitor and have demonstrated discase
progression on or within 60 days of completion of

LuciPoma

last therapy.
wath AIDS-related Kaposi sarcoma (KS) after failure

pfiarte etapy (HAARTlotin
MM:4mg per day t

Pomalidomide Capsules

FDA批准

of tepeated 28 dav cvcles until disease progression
Davs 1 throueh 20
Storage: in a dry place and store at 20°℃ to 25°℃

4mg

Aecp medicine out of reach of Children. Do nol
admraister LuciPoma during Pregnancy and
Lactation

PLEASE SEE PACKAGE INSERT

Rx Only

Manufsctared and Marketed by:
LUCIUS

权威认证

Thongmang village, Xaythany district, Vientiane
Warning: To be sold by retail on prescrintion
pgaczans only, and as directed
Dy the physician

21 Capsules

口碑质量

适应症:
泊马度胺是一种沙利度胺类似物,适用于治疗成年患者:
1、与地塞米松联合使用,适用于多发性骨髓瘤(MM)患者,这些患者之前接受
过至少两种治疗,包括来那度胺和蛋白酶体抑制剂,并且在最后一次治疗结
束后60天内或60天内出现疾病进展。

2、在高效抗逆转录病毒治疗(HAART)失败后患有艾滋病相关卡波济氏肉瘤
(KS)或HIV阴性KS患者。
推荐剂量:
1、MM:在28天周期的第1天至第21天,每日一次,每次4mg,直至疾病进展。
2、KS:在28天周期的第1天至第21天,每日一次,每次5mg:直至疾病进展或
发生不可接受的毒性。
3、肾功能损害或肝功能损害患者的剂量要适当调整。